Company Profile

RedHill Biopharma (NASDAQ: RDHL)
5:30 PM UTC, 07/03/24
Last: $0.36 Change: +0.00 %Change: +0.17% Volume: 236,986
Detailed Quote
Open: $ 0.36   Volume: 236,986
High: $ 0.37   Yield(%) 0.00
Low: $ 0.36   P/E Ratio (ttm): 0.10
Dividend ($): n/a   Market Cap ($): 11.47M
EPS ($) -3.16   Shares Out: 31.87M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -23.79
% Price Change (last 13 weeks): -31.70
% Price Change (last 26 weeks): -75.21
% Price Change (last 52 weeks): -69.58
% Price Change (year to date): -75.34
Management Effectiveness
Return on Equity (%): n/a
Return on Assets (%): 26.23
Return on Invested Capital (%): -134.65
Profitability
Gross Profit Margin (%): 47.03
Net Profit Margin (%): 366.25
Operating Profit Margin (%): -481.35
Price & Volume
50-day Moving Average: $0.43
200-day Moving Average: $0.66
Avg. Daily Vol. (last 50 days): 262,782
Avg. Daily Vol. (last 200 days): 3,820,182
52-wk high: $3.28
52-wk low: $0.26
Bid: $0.36
Ask: $0.36
Company Information
RedHill Biopharma Ltd. develops medicines for gastrointestinal and infectious diseases. It operates through Commercial Operations, and the Research and Development segments. The Commercial Operations segment covers all areas relating to the commercial sales and is being performed by the subsidiary in the U.S. The Research and Development segment includes the study and licensing of therapeutic candidates. Its products include Talicia, Movantik, and Aemcolo. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.
RedHill Biopharma
21 Ha'arba'a Street
Tel Aviv TA 6473921

Phone: 972.3.541.3131
Fax: 972.3.541.3144
http://www.redhillbio.com
Per Share Data
Earnings (1year) ($): -3.16
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): 0.10
Book Value ($): 0.11
Cash Flow ($): 1.31
Valuation Ratios
Price/Earnings (x): 0.10
Price/Sales (x): 1.45
Price/Book (x): 13.88
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 0.54
Current Ratio (x): 0.84
LT Debt/Equity (x): 21.99
Total Debt/Equity (x): 56.69



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.